Greenbrook TMS Announces Results of Voting at Annual Meeting of Shareholders

Rhea-AI Summary

Greenbrook TMS Inc. (NASDAQ: GBNH) announced the results of its shareholders' annual meeting, where 10,711,474 common shares (60.17% of outstanding shares) were represented. All nominated directors were elected with high approval ratings, including 99.97% for Brian P. Burke and full support for Colleen Campbell and others. KPMG LLP was reappointed as the Company’s auditor, receiving 100% of votes in favor. Greenbrook operates 148 treatment centers in the U.S., delivering over 840,000 TMS treatments to more than 24,000 patients for mental health issues.

Positive

• High approval ratings for elected directors, with up to 100% support.
• KPMG LLP reappointed as auditor with 100% votes in favor.
• Significant operational footprint with 148 treatment centers across the U.S.

Negative

• None.

TORONTO--(BUSINESS WIRE)-- Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the “Meeting”). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 11, 2022 (the “Circular”).

The total number of common shares represented at the Meeting was 10,711,474, representing approximately 60.17% of Greenbrook’s outstanding common shares entitled to be voted.

Election of Directors

All of the nominees listed in the Management Information Circular of Greenbrook prepared in connection with the Meeting were elected as directors by a resolution passed by a majority of the shareholders represented in person or by proxy at the Meeting, to hold office until the next annual meeting following their election or until their successors are elected or appointed. The following represents the votes received with regard to such matter:

Nominee	Votes For	% Votes For	Votes Withheld	% Votes Withheld
Brian P. Burke	9,966,607	99.97%	2,873	0.03%
Colleen Campbell	9,969,379	100.00%	101	0.00%
Sasha Cucuz	9,969,391	100.00%	89	0.00%
Adrienne Graves, Ph.D.	9,963,591	99.94%	5,889	0.06%
Robert Higgins	9,966,307	99.97%	3,173	0.03%
Bill Leonard	9,969,167	100.00%	313	0.00%
Adele C. Oliva	9,969,391	100.00%	89	0.00%
Frank Tworecke	9,966,218	99.97%	3,262	0.03%
Elias Vamvakas	9,969,378	100.00%	102	0.00%

Appointment of Auditors

KPMG LLP was reappointed as auditor of Greenbrook and the directors were authorized to fix the auditor’s remuneration by a resolution passed by a majority of the shareholders represented in person or by proxy at the Meeting. The following represents the votes received with regard to such matter:

Votes For	% Votes For	Votes Withheld	% Votes Withheld
10,711,174	100.00%	300	0.00%

About Greenbrook TMS Inc.

Operating through 148 Company-operated treatment centers, Greenbrook is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 840,000 TMS treatments to over 24,000 patients struggling with depression.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220621006123/en/

Glen Akselrod

Investor Relations

Greenbrook TMS Inc.

Contact Information:

investorrelations@greenbrooktms.com

1-855-797-4867

Source: Greenbrook TMS Inc.

FAQ

What were the results of Greenbrook TMS Inc.'s annual meeting?

During the annual meeting, all nominated directors were elected with high approval ratings, and KPMG LLP was reappointed as the auditor.

How many shares were represented at the Greenbrook TMS Inc. annual meeting?

10,711,474 common shares were represented, accounting for approximately 60.17% of outstanding shares.

Who were the elected directors of Greenbrook TMS Inc.?

Elected directors included Brian P. Burke, Colleen Campbell, Sasha Cucuz, and others, all receiving high vote percentages.

What is the stock symbol for Greenbrook TMS Inc.?

The stock symbol for Greenbrook is NASDAQ: GBNH.

What is the significance of the TMS therapy provided by Greenbrook?

Greenbrook TMS offers FDA-cleared, non-invasive therapy for Major Depressive Disorder and other mental health disorders.